Our finding is consistent with recent research that revealed the prominent role of IL-11 signaling in pulmonary fibrosis pathology (23), suggesting that IL-11 could serve as a potential drug target for the treatment of lung fibrosis and IPF. This evidence concerns the gene IL11 and idiopathic pulmonary fibrosis.